Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Caldon CE, Sergio CM, Schütte J, Boersma MN, Sutherland RL, Carroll JS, Musgrove EA.

Mol Cell Biol. 2009 Sep;29(17):4623-39. doi: 10.1128/MCB.00269-09. Epub 2009 Jun 29.

PMID:
19564413
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL.

Endocr Relat Cancer. 2003 Jun;10(2):179-86. Review.

PMID:
12790780
[PubMed - indexed for MEDLINE]
Free Article
3.

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL.

Mol Cell Biol. 1998 Aug;18(8):4499-508.

PMID:
9671459
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.

Cancer Res. 2002 Jun 1;62(11):3126-31.

PMID:
12036924
[PubMed - indexed for MEDLINE]
Free Article
5.

Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.

Mol Cell Biol. 2001 Feb;21(3):794-810.

PMID:
11154267
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.

Benaud CM, Dickson RB.

Oncogene. 2001 Jul 27;20(33):4554-67.

PMID:
11494151
[PubMed - indexed for MEDLINE]
Free Article
7.

The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.

Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.

Oncogene. 2008 Jan 10;27(3):366-77. Epub 2007 Jul 16.

PMID:
17637753
[PubMed - indexed for MEDLINE]
8.

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H.

EMBO J. 1999 Oct 1;18(19):5310-20.

PMID:
10508164
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.

Hiyama H, Iavarone A, LaBaer J, Reeves SA.

Oncogene. 1997 May 29;14(21):2533-42.

PMID:
9191053
[PubMed - indexed for MEDLINE]
Free Article
10.

Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.

Qi Y, Tu Y, Yang D, Chen Q, Xiao J, Chen Y, Fu J, Xiao X, Zhou Z.

J Cell Physiol. 2007 Jan;210(1):63-71.

PMID:
17013808
[PubMed - indexed for MEDLINE]
11.

The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.

Por E, Byun HJ, Lee EJ, Lim JH, Jung SY, Park I, Kim YM, Jeoung DI, Lee H.

J Biol Chem. 2010 May 7;285(19):14475-85. doi: 10.1074/jbc.M109.084400. Epub 2010 Mar 10.

PMID:
20220142
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Estrogen regulation of cell cycle progression in breast cancer cells.

Prall OW, Rogan EM, Sutherland RL.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):169-74. Review.

PMID:
9699870
[PubMed - indexed for MEDLINE]
14.

Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.

Caldon CE, Sergio CM, Kang J, Muthukaruppan A, Boersma MN, Stone A, Barraclough J, Lee CS, Black MA, Miller LD, Gee JM, Nicholson RI, Sutherland RL, Print CG, Musgrove EA.

Mol Cancer Ther. 2012 Jul;11(7):1488-99. doi: 10.1158/1535-7163.MCT-11-0963. Epub 2012 May 7.

PMID:
22564725
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.

Bindels EM, Lallemand F, Balkenende A, Verwoerd D, Michalides R.

Oncogene. 2002 Nov 21;21(53):8158-65.

PMID:
12444551
[PubMed - indexed for MEDLINE]
Free Article
17.

c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.

Mukherjee S, Conrad SE.

J Biol Chem. 2005 May 6;280(18):17617-25. Epub 2005 Mar 8.

PMID:
15757889
[PubMed - indexed for MEDLINE]
Free Article
18.

A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2.

Prall OW, Carroll JS, Sutherland RL.

J Biol Chem. 2001 Nov 30;276(48):45433-42. Epub 2001 Oct 1.

PMID:
11581254
[PubMed - indexed for MEDLINE]
Free Article
19.

Roles of E2F1 in mesangial cell proliferation in vitro.

Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F.

Kidney Int. 1999 Dec;56(6):2085-95.

PMID:
10594784
[PubMed - indexed for MEDLINE]
Free Article
20.

The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.

Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ Jr, Cornetta K.

Biochem Biophys Res Commun. 2000 Apr 21;270(3):1144-53.

PMID:
10772965
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk